Display options
Share it on

Adv Sci (Weinh). 2015 Jul 15;2(11):1500122. doi: 10.1002/advs.201500122. eCollection 2015 Nov.

Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Anwarul Hasan, Ahmad Khattab, Mohammad Ariful Islam, Khaled Abou Hweij, Joya Zeitouny, Renae Waters, Malek Sayegh, Md Monowar Hossain, Arghya Paul

Affiliations

  1. Center for Biomedical Engineering Department of Medicine Brigham and Women's Hospital Harvard Medical School Cambridge MA 02139 USA; Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology Cambridge MA 02139 USA; Biomedical Engineering and Department of Mechanical Engineering Faculty of Engineering and Architecture American University of Beirut Beirut 1107 2020 Lebanon.
  2. Department of Electrical and Computer Engineering Faculty of Engineering and Architecture American University of Beirut Beirut 1107 2020 Lebanon.
  3. Laboratory of Nanomedicine and Biomaterials Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA; Laboratory for Nanoengineering and Drug Delivery Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA.
  4. Department of Mechanical Engineering Faculty of Engineering and Architecture American University of Beirut Beirut 1107 2020 Lebanon.
  5. BioIntel Research Laboratory Department of Chemical and Petroleum Engineering Bioengineering Graduate Program School of Engineering University of Kansas Lawrence KS 66045 USA.
  6. Hamilton College Clinton NY 13323 USA.
  7. Department of Medicine Lyell McEwin Hospital University of Adelaide South Australia 5112 Australia.

PMID: 27668147 PMCID: PMC5033116 DOI: 10.1002/advs.201500122

Abstract

Cardiac tissue damage due to myocardial infarction (MI) is one of the leading causes of mortality worldwide. The available treatments of MI include pharmaceutical therapy, medical device implants, and organ transplants, all of which have severe limitations including high invasiveness, scarcity of donor organs, thrombosis or stenosis of devices, immune rejection, and prolonged hospitalization time. Injectable hydrogels have emerged as a promising solution for in situ cardiac tissue repair in infarcted hearts after MI. In this review, an overview of various natural and synthetic hydrogels for potential application as injectable hydrogels in cardiac tissue repair and regeneration is presented. The review starts with brief discussions about the pathology of MI, its current clinical treatments and their limitations, and the emergence of injectable hydrogels as a potential solution for post MI cardiac regeneration. It then summarizes various hydrogels, their compositions, structures and properties for potential application in post MI cardiac repair, and recent advancements in the application of injectable hydrogels in treatment of MI. Finally, the current challenges associated with the clinical application of injectable hydrogels to MI and their potential solutions are discussed to help guide the future research on injectable hydrogels for translational therapeutic applications in regeneration of cardiac tissue after MI.

Keywords: cardiac repair; hydrogels; myocardial infarction; regenerative medicine; stem cell; tissue engineering

References

  1. J Am Coll Cardiol. 2005 Aug 16;46(4):714-9 - PubMed
  2. Expert Rev Med Devices. 2011 Sep;8(5):607-26 - PubMed
  3. J Cardiovasc Transl Res. 2011 Oct;4(5):528-42 - PubMed
  4. Tissue Eng. 2004 Mar-Apr;10(3-4):403-9 - PubMed
  5. J Control Release. 2002 Sep 18;83(1):53-63 - PubMed
  6. Adv Sci (Weinh). 2015 Jul 15;2(11):1500122 - PubMed
  7. Biophys J. 2008 Apr 1;94(7):2914-25 - PubMed
  8. Circulation. 2000 Nov 7;102(19 Suppl 3):III56-61 - PubMed
  9. Biomaterials. 1999 Jan;20(1):45-53 - PubMed
  10. Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11507-12 - PubMed
  11. J Biomed Mater Res. 2000 Aug;51(2):164-71 - PubMed
  12. Bioconjug Chem. 1995 Mar-Apr;6(2):150-65 - PubMed
  13. Transplantation. 1997 Mar 27;63(6):795-803 - PubMed
  14. Mar Drugs. 2011 Dec;9(12):2514-25 - PubMed
  15. J Heart Lung Transplant. 2010 Aug;29(8):881-7 - PubMed
  16. Adv Drug Deliv Rev. 2000 Aug 20;42(1-2):65-80 - PubMed
  17. J Biomech. 2014 Jun 27;47(9):1949-63 - PubMed
  18. Biotechnol Prog. 2001 Sep-Oct;17(5):945-50 - PubMed
  19. J Biomed Mater Res A. 2015 Mar;103(3):907-18 - PubMed
  20. J Cardiovasc Nurs. 2009 Mar-Apr;24(2):87-92 - PubMed
  21. ACS Nano. 2014 Aug 26;8(8):8050-62 - PubMed
  22. Acta Biomater. 2014 Jan;10(1):11-25 - PubMed
  23. Expert Opin Drug Deliv. 2013 Jan;10(1):59-72 - PubMed
  24. PLoS One. 2009 Jun 23;4(6):e6005 - PubMed
  25. Biomaterials. 2014 Feb;35(5):1429-38 - PubMed
  26. Biomaterials. 2000 Nov;21(21):2155-61 - PubMed
  27. Mini Rev Med Chem. 2011 Mar;11(3):263-70 - PubMed
  28. Chem Soc Rev. 2008 Aug;37(8):1473-81 - PubMed
  29. Trends Biotechnol. 2002 Jan;20(1):16-21 - PubMed
  30. J Am Coll Cardiol. 2004 Aug 4;44(3):654-60 - PubMed
  31. J Biomed Mater Res. 1999 Oct;47(1):46-53 - PubMed
  32. J Interv Cardiol. 2007 Jun;20(3):188-96 - PubMed
  33. Tissue Eng. 2003 Aug;9(4):679-88 - PubMed
  34. Neurol Res. 1998 Oct;20(7):648-54 - PubMed
  35. ACS Nano. 2013 Mar 26;7(3):2369-80 - PubMed
  36. Cardiology. 2010;115(3):194-9 - PubMed
  37. Acta Biomater. 2010 Jun;6(6):1978-91 - PubMed
  38. Acta Biomater. 2015 Mar;14:84-95 - PubMed
  39. Adv Mater. 2009 Sep 4;21(32-33):3307-29 - PubMed
  40. Biomaterials. 2008 Aug;29(23):3346-56 - PubMed
  41. Adv Funct Mater. 2013 Oct 18;23(39): - PubMed
  42. J Biomed Mater Res B Appl Biomater. 2009 Oct;91(1):163-71 - PubMed
  43. J Am Chem Soc. 2009 Jul 8;131(26):9204-6 - PubMed
  44. Ann Thorac Surg. 2008 Oct;86(4):1268-76 - PubMed
  45. Artif Organs. 2006 Feb;30(2):86-93 - PubMed
  46. J Mol Cell Cardiol. 2002 Feb;34(2):107-16 - PubMed
  47. ALTEX. 1998;15(5):87 - PubMed
  48. Biomaterials. 2011 Dec;32(35):9290-9 - PubMed
  49. Biomaterials. 2008 Jun;29(18):2757-66 - PubMed
  50. Pharmacol Ther. 2005 Feb;105(2):151-63 - PubMed
  51. J Biomed Mater Res A. 2003 Jan 1;64(1):70-9 - PubMed
  52. Cardiovasc Res. 2007 Jul 1;75(1):178-85 - PubMed
  53. Chem Pharm Bull (Tokyo). 2000 Jun;48(6):850-4 - PubMed
  54. Biomaterials. 2009 Sep;30(26):4357-68 - PubMed
  55. Expert Rev Cardiovasc Ther. 2012 Aug;10(8):1039-49 - PubMed
  56. Chem Soc Rev. 2012 Mar 21;41(6):2193-221 - PubMed
  57. Biomaterials. 2014 Apr;35(13):3986-98 - PubMed
  58. Biomaterials. 2014 Aug;35(26):7308-25 - PubMed
  59. J Biomed Mater Res. 1998 Jun 5;40(3):392-400 - PubMed
  60. J Cell Mol Med. 2010 May;14(5):1044-55 - PubMed
  61. Biotechnol Bioeng. 2014 Mar;111(3):441-53 - PubMed
  62. Tissue Eng Part A. 2009 Jun;15(6):1437-47 - PubMed
  63. Nat Med. 2006 Apr;12(4):459-65 - PubMed
  64. Biomaterials. 2012 Apr;33(11):3093-106 - PubMed
  65. Bioconjug Chem. 1999 Jan-Feb;10(1):75-81 - PubMed
  66. Adv Sci (Weinh). 2015 Jan 21;2(1-2):1400010 - PubMed
  67. Stem Cells. 2010 Nov;28(11):2088-98 - PubMed
  68. Science. 1999 Jan 1;283(5398):65-7 - PubMed
  69. Acta Biomater. 2007 Jan;3(1):33-41 - PubMed
  70. Nature. 2008 Feb 21;451(7181):937-42 - PubMed
  71. J Biomed Mater Res. 2000 Sep 5;51(3):343-51 - PubMed
  72. Nanotechnology. 2014 Jan 10;25(1):014011 - PubMed
  73. Nanotechnology. 2012 Sep 28;23(38):385102 - PubMed
  74. J Am Coll Cardiol. 2011 Dec 13;58(25):2615-29 - PubMed
  75. Adv Drug Deliv Rev. 2014 May;71:115-30 - PubMed
  76. Biomed Res Int. 2014;2014:307519 - PubMed
  77. Nanomaterials (Basel). 2013 May 17;3(2):303-316 - PubMed
  78. J Biomater Sci Polym Ed. 2001;12(1):77-88 - PubMed
  79. J Thorac Cardiovasc Surg. 2004 Oct;128(4):571-8 - PubMed
  80. Bioconjug Chem. 1995 Jul-Aug;6(4):332-51 - PubMed
  81. Eur J Cardiothorac Surg. 2000 May;17(5):587-91 - PubMed
  82. Biomaterials. 2011 Jan;32(2):579-86 - PubMed
  83. Circulation. 2007 Oct 9;116(15):1683-92 - PubMed
  84. Sci Transl Med. 2013 Feb 20;5(173):173ra25 - PubMed
  85. Adv Drug Deliv Rev. 2002 Oct 18;54(8):1057-73 - PubMed
  86. Bioconjug Chem. 1997 Sep-Oct;8(5):686-94 - PubMed
  87. J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23 - PubMed
  88. Biomacromolecules. 2001 Summer;2(2):430-41 - PubMed
  89. J Biomed Mater Res. 2000 Mar 5;49(3):305-11 - PubMed
  90. ACS Appl Mater Interfaces. 2015 Apr 1;7(12):6505-17 - PubMed
  91. Mar Drugs. 2010 Apr 19;8(4):1305-22 - PubMed
  92. Acta Biomater. 2009 Oct;5(8):2939-44 - PubMed
  93. Biomaterials. 2002 Nov;23(22):4315-23 - PubMed
  94. Acta Biomater. 2009 Mar;5(3):817-31 - PubMed
  95. Circulation. 2008 Mar 18;117(11):1388-96 - PubMed
  96. Biotechnol Adv. 2014 Mar-Apr;32(2):449-61 - PubMed
  97. J Biomed Mater Res. 2000 Mar 15;49(4):448-59 - PubMed
  98. Biomaterials. 2005 Jan;26(3):319-26 - PubMed
  99. J Thorac Cardiovasc Surg. 2008 Apr;135(4):799-808 - PubMed
  100. Tissue Eng Part A. 2008 Jun;14(6):1025-36 - PubMed
  101. Adv Drug Deliv Rev. 1998 Aug 3;33(1-2):111-139 - PubMed
  102. J Biomed Mater Res A. 2014 Oct;102(10):3452-8 - PubMed
  103. Chem Rev. 2001 Jul;101(7):1869-79 - PubMed
  104. Macromolecules. 1998 Jul 28;31(15):5059-70 - PubMed
  105. J Cell Mol Med. 2012 Jun;16(6):1310-20 - PubMed
  106. Biomaterials. 2009 Oct;30(29):5409-16 - PubMed
  107. J Cardiovasc Transl Res. 2011 Apr;4(2):177-81 - PubMed
  108. Circulation. 2005 Aug 30;112(9 Suppl):I173-7 - PubMed
  109. Adv Drug Deliv Rev. 1998 Jan 5;29(1-2):157-177 - PubMed
  110. Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1708-16 - PubMed
  111. J Biomed Mater Res. 2001 Aug;56(2):228-33 - PubMed
  112. Biol Pharm Bull. 1997 Dec;20(12):1290-4 - PubMed
  113. Nature. 1997 Aug 28;388(6645):860-2 - PubMed
  114. Biomaterials. 1990 Apr;11(3):162-8 - PubMed

Publication Types

Grant support